Composition :

Each capsule FORCANOX® contains Itraconazole 100 mg


Pharmacology :

FORCANOX® (Itraconazole) is a derivative of triazole, active in dermatophyte infection (Trichophyton spp, Microsporum spp, Epidermophyton floccosum), yeast (Candida spp, Pytirosporum spp), Aspergilus spp. In vitro Itraconazole can inhibit the most important component in fungal cell membrane


Indication :

FORCANOX® is indicated for vulvovaginal candidiasis, pityriasis versicolor, fungal keratitis and oral candidiasis, dermatomycosis.


Dosage :

  • Vulvovaginal candidiasis: 2 capsules (200 mg) in divided doses 2 times daily for a day or 2 capsules (200 mg) once per day for 3 days
  • Pytiriasis versicolor:
    2 capsules (200 mg per day) for 7 days
  • Tinea corporis, tinea cruris:
    1 capsule (100 mg per day) for 15 days
  • Dermatomycosis:
    1 capsule (100 mg per day) for 15 days. In areas with high keratinization such as tinea pedis, tinea manus, an additional treatment 100 mg per day is needed for another 15 days
  • Oral candidiasis:
    1 capsule (100 mg per day) for 15 days
  • Fungal keratitis:
    2 capsules (200 mg per day) for 21 days
  • In some immunocompromized patients such as neutropenia, AIDS or patients with organ transplant, the bioavailability of oral Itraconazole may decrease, therefore dosage should be given 2-fold

The elimination of FORCANOX® (Itraconazole) in the skin tissue is slower than in plasma, so clinically effect and optimally mycologic are achieved 2-4 weeks after treatment is stopped. To obtain maximum absorption, FORCANOX® (Itraconazole) should be taken immediately after meals. Unknown effect and side effects on the use of more than one month. Therefore FORCANOX® (Itraconazole) is not recommended for more than 1 (one) month.


Presentation and Registration Number :

FORCANOX® Box, 3 strips @ 6 capsules; DKL9508003401A1





Categorised in:

This post was written by admin